Annual Results Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Indrapr.Medical With
Figures in Cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
1,356.36
1,369.74
-13.38
-0.98%
Other Operating Income
0.00
1.38
-1.38
-100.00%
Total Operating income
1,356.36
1,371.12
-14.76
-1.08%
Raw Material Cost
230.46
368.42
-137.96
-37.45%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
277.10
251.18
25.92
10.32%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
355.18
0.00
355.18
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
249.35
365.80
-116.45
-31.83%
Total Expenditure (Excl Depreciation)
1,112.09
985.40
126.69
12.86%
Operating Profit (PBDIT) excl Other Income
244.27
385.72
-141.45
-36.67%
Other Income
22.65
22.10
0.55
2.49%
Operating Profit (PBDIT)
266.92
407.82
-140.90
-34.55%
Interest
6.27
32.68
-26.41
-80.81%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
260.65
375.14
-114.49
-30.52%
Depreciation
44.33
97.59
-53.26
-54.58%
Profit Before Tax
216.32
277.55
-61.23
-22.06%
Tax
55.33
68.61
-13.28
-19.36%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
160.99
208.95
-47.96
-22.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
160.99
208.95
-47.96
-22.95%
Equity Capital
91.67
10.94
80.73
737.93%
Face Value
10.00
10.00
0.00
Reserves
505.01
1,075.22
-570.21
-53.03%
Earnings per share (EPS)
17.56
191.00
-173.44
-90.81%
Diluted Earnings per share
17.56
190.95
-173.39
-90.80%
Operating Profit Margin (Excl OI)
18.01%
28.16%
0.00
-10.15%
Gross Profit Margin
19.22%
27.39%
0.00
-8.17%
PAT Margin
11.87%
15.25%
0.00
-3.38%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,356.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 160.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024
Annual - Interest
Interest 6.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.01%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
